PBSV (Pharma-Bio Serv) ROCE % : -4.27% (As of Oct. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Pharma-Bio Serv ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pharma-Bio Serv's annualized ROCE % for the quarter that ended in Oct. 2024 was -4.27%.

Pharma-Bio Serv ROCE % Historical Data

The historical data trend for Pharma-Bio Serv's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma-Bio Serv ROCE % Chart

Pharma-Bio Serv Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

ROCE %

Get a 7-Day Free Trial

9.07

-16.27

5.91

6.16

-8.01

Pharma-Bio Serv Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
ROCE %	Get a 7-Day Free Trial															-1.17	-10.52	-8.27	-10.48	-4.27

Pharma-Bio Serv ROCE % Calculation

Pharma-Bio Serv's annualized ROCE % for the fiscal year that ended in Oct. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Oct. 2024 )		(A: Oct. 2023 )		(A: Oct. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Oct. 2024 )		(A: Oct. 2023 )		(A: Oct. 2024 )
	=	-1.288	/	( ( (19.902 - 2.154)	+	(16.292 - 1.887) )	/ 2 )
	=	-1.288	/	( (17.748	+	14.405)	/ 2 )
	=	-1.288	/	16.0765
	=	-8.01 %

Pharma-Bio Serv's ROCE % of for the quarter that ended in Oct. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Oct. 2024 )		(Q: Jul. 2024 )		(Q: Oct. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Oct. 2024 )		(Q: Jul. 2024 )		(Q: Oct. 2024 )
	=	-0.616	/	( ( (16.319 - 1.899)	+	(16.292 - 1.887) )	/ 2 )
	=	-0.616	/	( ( 14.42	+	14.405 )	/ 2 )
	=	-0.616	/	14.4125
	=	-4.27 %

(1) Note: The EBIT data used here is four times the quarterly (Oct. 2024) EBIT data.

Pharma-Bio Serv (OTCPK:PBSV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pharma-Bio Serv ROCE % Related Terms

Thank you for viewing the detailed overview of Pharma-Bio Serv's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma-Bio Serv Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharma-Bio Serv Inc (OTCPK:PBSV) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Road 696, Pharma-Bio Serv Building, Dorado, PRI, 00646

Website

https://www.pharmabioserv.com

Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.

Executives

Elizabeth Plaza	10 percent owner	363 DORADO BEACH EAST, DORADO PR 00646
Altura Victor Sanchez	officer: President and CEO	C/O PHARMA-BIO SERV, INC., 6 ROAD 696, DORADO PR 00646
San Juan Holdings	10 percent owner	255 PONCE DE LEON, SUITE 305 MCS PLAZA, SAN JUAN PR 00917
Pedro J Lasanta	officer: Chief Financial Officer	373 MENDEZ VIGO, STE 110, DORADO PR 00646
Dov Perlysky	director	2 LAKESIDE DRIVE WEST, LAWRENCE NY 11559
L P Venturetek	10 percent owner	C/O DAVID SELENGUT ELLENOFF GROSSMAN, 370 LEXINGTON AVENUE 19TH FLOOR, NEW YORK NY 10017
Barron Partners Lp	10 percent owner	730 FIFTH AVENUE, 25TH FLOOR, NEW YORK NY 10019
Manuel O Morera	officer: Chief Financial Officer	373 MENDEZ VIGO, SUITE 110, DORADO PR 00646
Mark A Fazio	officer: Exec. Vice President and COO	P O BOX 1026 GREEN STREET, PERKASIE PA 18944
Kirk Wheeler Michel	director	209 EAST TRYON STREET, HILLSBOROUGH NC 27278
Irving L Wiesen	director	1273 NORTH AVENUE, APT 1E 7, NEW ROCHELLE NY 10804
Howard Spindel	director	39 BROADWAY SUITE 3300, NEW YORK NY 10028
Nelida Plaza Rodriguez	officer: Vice President and Secretary	G11 CALLE MADRE PERLA URB, DORADO DEL MAR, DORADO PR 00646
Krovim Llc	director, 10 percent owner, officer: Manager	P.O. BOX 339, LAWRENCE NY 11559